Salestools LogoSalestools
Agentes IA de Salestools
Soluciones
Recursos
Empresa
Precios
Salestools Logo

Salestools

El agente IA #1 para equipos de ventas y Go-to-Market. Vende más, más rápido, con menos esfuerzo.

Producto

  • Agentes de ventas IA
  • Datos de intención
  • Datos tecnológicos
  • Seguimiento de visitantes
  • Co-Pilot
  • Venta social

Soluciones

  • Servicio al cliente
  • Comercio electrónico
  • SaaS
  • Empresarial
  • Pequeña empresa

Recursos

  • El informe
  • Documentación
  • Referencia de API
  • Centro de ayuda
  • Blog
  • Casos de estudio
  • Webinars

Empresa

  • Acerca de
  • Carreras
  • Prensa
  • Contacto
  • Socios

Nuestras ubicaciones

  • Nueva York, HQ
  • Bucarest, laboratorio de investigación IA
  • Zug, Suiza

© 2026 Salestools. Todos los derechos reservados.

Términos de datos y seguridadPolítica de privacidadTérminos de servicioAcceptable Use
Todos los sistemas operativos
Salestools LogoSalestools
Agentes IA de Salestools
Soluciones
Recursos
Empresa
Precios
Back to Reports
Fundraising

LMArena

LMArena Raises $100M in Seed

Berkeley, CAMay 21, 20252 min read
Employees
40+

LMArena Raises $100M in Seed


LMArena has successfully raised $100M in a Seed at a $600M valuation led by Andreessen Horowitz, UC Investments.


Company Overview


LMArena is a AI/ML company headquartered in Berkeley, CA, founded in 2024 with 40+ employees.


AI model benchmarking and evaluation platform for comparing language models


Fundraising Details


  • Amount Raised: $100M
  • Round Type: Seed
  • Valuation: $600M
  • Date: 2025-05-21
  • Investors: Andreessen Horowitz, UC Investments

About LMArena


AI model benchmarking and evaluation platform for comparing language models The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Berkeley, CA
  • Founded: 2024
  • Team Size: 40+
  • Industry: AI/ML

What This Means


This funding round demonstrates strong investor confidence in LMArena's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. LMArena's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $600M valuation marks an important milestone for LMArena, positioning the company among notable players in the AI/ML industry.


Looking Ahead


With this new capital, LMArena is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-05-21. For more information about LMArena, visit their headquarters at Berkeley, CA.

Company Info

Headquarters
Berkeley, CA
Founded
2024
Team Size
40+

Topics

Fundraising(2912)AI/ML(484)SeedLMArena

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free